These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18405986)

  • 1. Can protons improve SBRT for lung lesions? Dosimetric considerations.
    Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
    Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
    Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
    Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy.
    Hillbrand M; Georg D; Gadner H; Pötter R; Dieckmann K
    Radiother Oncol; 2008 Nov; 89(2):141-9. PubMed ID: 18692928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
    Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience.
    Taghian AG; Kozak KR; Katz A; Adams J; Lu HM; Powell SN; DeLaney TF
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1404-10. PubMed ID: 16730137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
    Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
    Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
    Johansson J; Blomquist E; Montelius A; Isacsson U; Glimelius B
    Radiother Oncol; 2004 Aug; 72(2):129-38. PubMed ID: 15297132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
    Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
    Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.